| Title: |
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis |
| Authors: |
Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Barbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris |
| Contributors: |
Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Barbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris |
| Publication Year: |
2021 |
| Collection: |
IRIS Università degli Studi di Bologna (CRIS - Current Research Information System) |
| Subject Terms: |
Dipeptidyl-peptidase-4 inhibitor; Glucagon like peptide-1 receptor agonist; NAFLD; Sodium-glucose cotransporter-2 inhibitor; Surrogate biomarkers |
| Description: |
There is intense research for drugs able to reduce disease progression in NAFLD. We aimed to test the impact of novel antidiabetic drugs (dipeptidyl-peptidase-4 inhibitors - DPP-4Is, glucagon-like peptide-1 receptor agonists - GLP-1RAs, sodium-glucose cotransporter-2 inhibitors - SGLT-2Is) on non-invasive biomarkers of steatosis (Fatty liver index, FLI) and fibrosis (Fibrosis-4 score, FIB-4) in patients with type 2 diabetes (T2D). |
| Document Type: |
article in journal/newspaper |
| File Description: |
ELETTRONICO |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/33497019; info:eu-repo/semantics/altIdentifier/wos/WOS:000616678500001; volume:41; issue:4; firstpage:731; lastpage:742; numberofpages:12; journal:LIVER INTERNATIONAL; https://hdl.handle.net/11585/829714 |
| DOI: |
10.1111/liv.14799 |
| Availability: |
https://hdl.handle.net/11585/829714; https://doi.org/10.1111/liv.14799; https://onlinelibrary.wiley.com/doi/full/10.1111/liv.14799 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.4DA5D1F6 |
| Database: |
BASE |